Laboratory Corporation of America 1st in US to offer blood-based CRC screening test: 4 key notes

Laboratory Corporation of America, a healthcare diagnostics, is the first United States-based laboratory to offer Epi proColon, a blood-based test for colorectal cancer screening.

Here are four key notes:

1. Epigenomics developed the test, and it is available in the U.S. through a joint commercialization agreement with Polymedco.

2. The Epi proColon test detects Epigenomics proprietary Septin9 DNA methylation biomarker for colorectal cancer in cell-free DNA circulating in blood.

3. The test was approved by the FDA in April.

4. Epi proColon provides an alternative to stool testing or colonoscopy.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast